SK pharmteco’s Post

We’re thrilled to share our latest white paper, which explores how SK pharmteco has evolved the HEK293 cell line to become a game-changer in viral vector manufacturing. 🔬 This comprehensive resource examines how we've enhanced these cells to boost titers and significantly reduce manufacturing costs. Key highlights include: • 𝗢𝗽𝘁𝗶𝗺𝗮𝗹 𝗖𝗲𝗹𝗹𝘀: Discover the importance of selecting the right cells lines for generating CGMP Master Cell Banks. • 𝗧𝗲𝗰𝗵𝗻𝗶𝗰𝗮𝗹 𝗔𝗱𝘃𝗮𝗻𝗰𝗲𝗺𝗲𝗻𝘁𝘀: Learn about the technical challenges and solutions in developing a high-performing, monoclonal suspension HEK293 cell line for CGMP cell banking. • 𝗜𝗺𝗽𝗮𝗰𝘁 𝗼𝗻 𝗣𝗿𝗼𝗱𝘂𝗰𝘁𝗶𝗼𝗻: Our CGMP Serum-free Suspension Cell Line for Universal AAV, LVV, and Ad vectors Production is simplifying the delivery of Advanced Therapies. Whether you're involved in bioprocessing, or viral vector production, this white paper is an invaluable resource for enhancing quality of vector preps, overall scalability, and lowering COGS of your CGMP vector. 🔗 Click the link in the comments to download the white paper and stay ahead in the rapidly evolving world of viral vector manufacturing. #ViralVector #GeneTherapy #Bioprocessing #AAV #LVV #Adeno #Vector #CGMP #Biotech

To view or add a comment, sign in

Explore topics